Handa Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development of niche portfolios. The company’s business strategy comprises utilizing our Taiwan headquarter as our global R&D center and establishing our presence in the world’s two largest pharmaceutical markets (the US and China).

We specialize in controlled-release technology and products that are difficult to formulate. Our business model includes managing all aspects of the product development process through the submission of its 505(b)(2) New Drug Applications (NDA) and High barrier-Abbreviated New Drug Applications (ANDA) to the United States Food and Drug Administration (FDA).